Applications
NSAIDS on Synergi Polar-RP 4 µm by SFC
18985
Separation Mode: Reversed Phase
Reversed Phase
Polar-RP
HPLC
Cyclooxygenase Inhibitors
Pharmaceutical
Therapeutic / Clinical

Applications

NSAIDS on Synergi Polar-RP 4 µm by SFC

Analytes

1
2
3
4
Compound Name
Naproxen
CID
156391
Molecular Formula
C14H14O3
Molecular Weight
230
No. Hydrogen Bond Acceptors
3
No. Hydrogen Bond Donors
1

Conditions

LC Conditions (App ID: 18985)
Column:Synergi 4 µm Polar-RP 80 Å, LC Column 250 x 4.6 mm, Ea
Brand Name:Synergi
Part No:00G-4336-E0
Elution Type:Gradient
Mobile Phase:A: Methanol
B: Carbon Dioxide
Gradient Profile:
Step No.Time(min)%A%B
10595
25.55050
37.55050
Flow Rate:3 mL/min
Temperature:40°C
Detection:UV-Vis Abs.-Fixed Wave. (UV) nm @ 40°C

Order Items Used in This Application

Similar Applications
No Data